Contracting a non-COVID lower respiratory tract infection raises the risk of death 2 to 7 times over the next month to a year ...

The S&P 500 and the Dow Jones Industrial Average ended higher on Monday, as the benchmarks temporarily shook off the uncertainty around the Trump administration's upcoming tariff plans which had ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official, Peter ...

Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

BEIJING - US pharmaceutical giant Pfizer's new research and development (R&D) center officially opened at BioPark in the ...

Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with ...

While tariffs have triggered market volatility, certain pharmaceutical stocks still present strong investment opportunities.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...